Cardiol Therapeutics Inc (CRDL)
1.84
+0.08
(+4.55%)
USD |
NASDAQ |
Apr 25, 16:00
1.75
-0.09
(-4.89%)
After-Hours: 20:00
Cardiol Therapeutics Cash from Investing (TTM): -0.0476M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -0.0476M |
September 30, 2023 | -0.0768M |
June 30, 2023 | -0.0794M |
March 31, 2023 | -0.0778M |
December 31, 2022 | -0.0574M |
September 30, 2022 | -0.0206M |
June 30, 2022 | -0.0241M |
March 31, 2022 | -0.0225M |
December 31, 2021 | -0.0103M |
September 30, 2021 | -0.0202M |
June 30, 2021 | -0.0158M |
Date | Value |
---|---|
March 31, 2021 | -0.0168M |
December 31, 2020 | -0.0303M |
September 30, 2020 | -0.0778M |
June 30, 2020 | -0.2515M |
March 31, 2020 | -0.3269M |
December 31, 2019 | -0.3197M |
September 30, 2019 | -0.2662M |
June 30, 2019 | -0.0483M |
March 31, 2019 | -0.0169M |
December 31, 2018 | -0.0106M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.3269M
Minimum
Mar 2020
-0.0103M
Maximum
Dec 2021
-0.0942M
Average
-0.0483M
Median
Jun 2019
Cash from Investing (TTM) Benchmarks
Aurinia Pharmaceuticals Inc | -6.706M |
Acasti Pharma Inc | -1.452M |
Edesa Biotech Inc | 0.00 |
Lexaria Bioscience Corp | -0.1991M |
Xenon Pharmaceuticals Inc | -117.17M |